Literature DB >> 21088149

Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

Elizabeth M Genega1, Musie Ghebremichael, Robert Najarian, Yineng Fu, Yihong Wang, Pedram Argani, Chiara Grisanzio, Sabina Signoretti.   

Abstract

Carbonic anhydrase IX (CAIX), a hypoxia-induced protein, is expressed in some renal tumors. We evaluated its immunohistochemical expression in 317 primary and 42 metastatic renal neoplasms (186 clear cell, 52 papillary, 35 chromophobe, 47 unclassified, and 15 Xp11.2 translocation renal cell carcinomas [RCCs]; 26 oncocytomas; 2 metanephric adenomas; 1 urothelial carcinoma; 1 mixed epithelial and stromal tumor; and 1 angiomyolipoma); 7 neoplasms were unknown as to whether they were primary or metastatic. We also correlated expression with tumor type and grade. Variable staining was seen in clear cell, papillary, unclassified, and Xp11.2 translocation carcinomas. One chromophobe carcinoma had focal expression. No staining was seen with other tumors. An association was found between high expression and clear cell vs non-clear cell carcinomas with all cases (P < .01) and primary (P < .01) cases. An association between CAIX expression and grade (P < .01) in primary clear cell carcinomas was found. CAIX expression is more common in clear cell RCC than other renal tumor types and is associated with grade.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088149      PMCID: PMC3778911          DOI: 10.1309/AJCPPPR57HNJMSLZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

1.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Authors:  S Ivanov; S Y Liao; A Ivanova; A Danilkovitch-Miagkova; N Tarasova; G Weirich; M J Merrill; M A Proescholdt; E H Oldfield; J Lee; J Zavada; A Waheed; W Sly; M I Lerman; E J Stanbridge
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney.

Authors:  E Oosterwijk; D J Ruiter; P J Hoedemaeker; E K Pauwels; U Jonas; J Zwartendijk; S O Warnaar
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

Review 3.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

4.  Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Authors:  Matthew H T Bui; David Seligson; Ken-ryu Han; Allan J Pantuck; Frederick J Dorey; Yunda Huang; Steve Horvath; Bradley C Leibovich; Shefali Chopra; Shu-Yuan Liao; Eric Stanbridge; Michael I Lerman; Aarno Palotie; Robert A Figlin; Arie S Belldegrun
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 5.  The von Hippel-Lindau tumor suppressor gene and kidney cancer.

Authors:  William G Kaelin
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

6.  Carbonic anhydrase isozymes IX and XII in gastric tumors.

Authors:  Mari Leppilampi; Juha Saarnio; Tuomo J Karttunen; Jyrki Kivelä; Silvia Pastoreková; Jaromir Pastorek; Abdul Waheed; William S Sly; Seppo Parkkila
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

7.  Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Authors:  Pedram Argani; Priti Lal; Brian Hutchinson; Man Yee Lui; Victor E Reuter; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

8.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

Review 9.  Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy.

Authors:  Michael B Atkins
Journal:  Med Oncol       Date:  2009-01-23       Impact factor: 3.064

Review 10.  Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.

Authors:  C P S Potter; A L Harris
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more
  33 in total

1.  Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.

Authors:  Mitchell L Ramsey; Benjamin J Yuh; Matthew T Johnson; Anjana V Yeldandi; Debra L Zynger
Journal:  Virchows Arch       Date:  2011-12-06       Impact factor: 4.064

2.  Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.

Authors:  Feray Kockar; Hatice Yildrim; Rahsan Ilikci Sagkan; Carsten Hagemann; Yasemin Soysal; Jelena Anacker; Ahmed Ayad Hamza; Dirk Vordermark; Michael Flentje; Harun M Said
Journal:  World J Clin Oncol       Date:  2012-06-10

3.  Renal tumors: diagnostic and prognostic biomarkers.

Authors:  Puay Hoon Tan; Liang Cheng; Nathalie Rioux-Leclercq; Maria J Merino; George Netto; Victor E Reuter; Steven S Shen; David J Grignon; Rodolfo Montironi; Lars Egevad; John R Srigley; Brett Delahunt; Holger Moch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

Review 4.  Carbonic anhydrases as disease markers.

Authors:  Sabina Zamanova; Ahmed M Shabana; Utpal K Mondal; Marc A Ilies
Journal:  Expert Opin Ther Pat       Date:  2019-06-17       Impact factor: 6.674

5.  Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade.

Authors:  Yi-Feng Gu; Shannon Cohn; Alana Christie; Tiffani McKenzie; Nicholas Wolff; Quyen N Do; Ananth J Madhuranthakam; Ivan Pedrosa; Tao Wang; Anwesha Dey; Meinrad Busslinger; Xian-Jin Xie; Robert E Hammer; Renée M McKay; Payal Kapur; James Brugarolas
Journal:  Cancer Discov       Date:  2017-05-04       Impact factor: 39.397

Review 6.  Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium.

Authors:  Yana Chervona; Adriana Arita; Max Costa
Journal:  Metallomics       Date:  2012-04-03       Impact factor: 4.526

Review 7.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?

Authors:  Jianbo Li; Guojian Zhang; Xuemei Wang; Xiao-Feng Li
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 8.  Biomarkers in renal cancer.

Authors:  Holger Moch; John Srigley; Brett Delahunt; Rodolfo Montironi; Lars Egevad; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

9.  Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.

Authors:  Ashley Cimino-Mathews; Rajni Sharma; George J Netto
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

10.  CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

Authors:  Jonathan M Weiss; W Gregory Alvord; Octavio A Quiñones; Jimmy K Stauffer; Robert H Wiltrout
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.